Risk of vertebral fracture and relationship to bone mineral density in steroid treated rheumatoid arthritis
Article Abstract:
The risk for spinal bone damage may be higher in post-menopausal women with rheumatoid arthritis (RA) than post-menopausal women in the general population. However, it remains unclear whether corticosteroid drug therapy contributes to this risk and whether bone mineral density (BMD) measurements are meaningful indicators of RA disease progression. Researchers compared spinal X-rays of 76 post-menopausal women with RA with the spinal X-rays of 347 age-matched volunteers (X-ray control group). They also compared BMD measurements of the RA group with 20 age-matched volunteers. Women in the RA group had a higher percentage of spinal injuries as compared to the X-ray control group. Both of these groups had a similar distribution of spinal injury types. Despite a 10%-16% overall decrease in BMD in the RA group, BMD measurements did not correlate with degree of spinal injury or use of corticosteroids.
Publication Name: Annals of the Rheumatic Diseases
Subject: Health
ISSN: 0003-4967
Year: 1995
User Contributions:
Comment about this article or add new information about this topic:
Bone mineral density and bone turnover in spinal osteoarthrosis
Article Abstract:
An increase in bone mineral density (BMD) may protect women with osteoarthrosis (OA) of the spine against bone loss. BMD is a frequently used measurement for evaluating bone mass. Doctors evaluated 375 volunteer women aged 50-85 for evidence of OA and spinal abnormalities by X-raying their spines. They also tested these women for BMD in the spine, hip, and total body and measured bone turnover rates as indicated by levels of excreted pyridinoline and deoxpyridinoline, and serum bone specific alkaline phosphatase. A total of 340 of the 375 women had OA. All of the BMD measurements were higher in the women with OA as compared to those without OA. The women with OA tended to have fewer vertebral deformities as compared to the women without OA. There was a significant association between spinal OA, higher BMD and lower rates of bone turnover.
Publication Name: Annals of the Rheumatic Diseases
Subject: Health
ISSN: 0003-4967
Year: 1995
User Contributions:
Comment about this article or add new information about this topic:
Mechanical and material properties of the subchondral bone plate from the femoral head of patients with osteoarthritis or osteoporosis
Article Abstract:
Osteoarthritis appears to affect bone as well as cartilage even in the early stages of the disease. Researchers took bone samples from various parts of the head of the upper leg bone removed from patients undergoing hip replacement. Most of the patients had osteoporosis (OP) or osteoarthritis (OA). Compared to bone from healthy volunteers, the bone samples of both the OP and OA patients were less stiff and dense. OP and OA bone had less mineralization. This indicates that bone demineralization alone does not cause OA, since cartilage remains intact in OP patients whereas both groups had bone demineralization.
Publication Name: Annals of the Rheumatic Diseases
Subject: Health
ISSN: 0003-4967
Year: 1997
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Increased levels of serum IgM antibody to staphylococcal enterotoxin B in patients with rheumatoid arthritis. Cytokine production by endothelial cells infected with human T cell lymphotropic virus type I
- Abstracts: Contribution of biofilm bacteria to the contamination of the dental unit water supply. Molecular techniques reveal high prevalence of Legionella in dental units
- Abstracts: Medicaid reforms clear Senate panel; veto looms. Kinder, gentler Medicaid reform. Feds act to shed role as guardian of nation's health
- Abstracts: Seroprevalence of HIV infection in the general population of the Cote d'Ivoire, West Africa. The epidemic of HIV AIDS in Abidjan, Cote d'Ivoire: a review of data collected by Projet RETRO-CI from 1987 to 1993
- Abstracts: Viral load in peripheral blood mononuclear cells as surrogate for clinical progression. Virologic parameters as surrogate markets for clinical outcome in HIV-1 disease: verification, variation and validation